GlassScriptPhysician profile
Adnan Kaleli
NPI 1437138716
$747.27
in general payments reported to CMS, 2019-2025
10 companies · $191 in 2025
The $191 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2021: $47.35 · 2022: $54.40 · 2024: $23.47 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $214.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $330.00 | 2019 | |
| Merck Sharp & Dohme LLC | $107.86 | 2025 | Keytruda |
| Astellas Pharma US INC | $100.62 | 2019 | |
| Telix Pharmaceuticals | $83.57 | 2025 | Illuccix |
| Progenics Pharmaceuticals, INC. | $29.17 | 2021 | |
| Myriad Genetic Laboratories, INC. | $27.66 | 2022 | |
| Boston Scientific Corporation | $26.74 | 2022 | |
| Abbvie INC. | $23.47 | 2024 | |
| Urovant Sciences INC | $18.18 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adnan Kaleli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.